Morning Market Movers
Sunesis Pharmaceuticals (NASDAQ: SNSS) surged 47.73% to $3.90. Sunesis Pharmaceuticals reported that it will implement a one-time, 225-patient sample size increase to its Phase 3 VALOR trial of vosaroxin in acute myeloid leukemia (AML).
Dehaier Medical Systems Limited (NASDAQ: DHRM) surged 15.63% to $1.85. Dehaier Medical has obtained State Food and Drug Administration approval for DHR-CPAP-C5.
Cell Therapeutics (NASDAQ: CTIC) climbed 15.13% to $2.96. Cell Therapeutics announced the initiation of the commercial launch of Pixuvri® in the European Union.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.